Altimmune, Inc.
NASDAQ:ALT · NASDAQ Global Market
+$0.08 today
Vol 9.00M · Avg 3.81M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-61.37%
Period High
$7.71
Period Low
$2.59
Latest
$2.70
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$849.55M
Alto Neuroscience, Inc.
NYSE:ANRO
$785.75M
Annexon, Inc.
NASDAQ:ANNX
$593.07M
Aura Biosciences, Inc.
NASDAQ:AURA
$397.08M
DBV Technologies S.A.
NASDAQ:DBVT
$381.73M
Amarin Corporation plc
NASDAQ:AMRN
$334.65M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$305.94M
AC Immune S.A.
NASDAQ:ACIU
$242.22M
Korro Bio, Inc.
NASDAQ:KRRO
$128.84M
enGene Holdings Inc.
NASDAQ:ENGN
$88.06M
What is the latest ALT filing?
The latest filing shown is 8-K dated Jun 16, 2026.
How many recent filings does ALT have?
Intrinsic Alpha currently shows 20 recent filings for ALT.
Explore More
Continue the stock analysis
Jump to another research area for this company.